Cargando…

SMAD7 loci contribute to risk of hepatocellular carcinoma and clinicopathologic development among Chinese Han population

Genome-wide association studies (GWAS) have identified three loci at 18q21 (rs4939827, rs7240004, and rs7229639), which maps to SMAD7 loci, were associated with risk of diseases of the digestive system. However, their associations with hepatocellular carcinoma (HCC) risk remain unknown. A case-contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Jiansong, Xu, Min, Zhao, Zhongwei, Tu, Jianfei, Gao, Jun, Lu, Chenying, Song, Jingjing, Chen, Weiqian, Chen, Minjiang, Fan, Xiaoxi, Cheng, Xingyao, Lan, Xilin, Li, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008354/ https://www.ncbi.nlm.nih.gov/pubmed/26989026 http://dx.doi.org/10.18632/oncotarget.8065

Ejemplares similares

MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinoma
por: Ji, Jiansong, et al.
Publicado: (2016)

CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance
por: Xu, Min, et al.
Publicado: (2018)

(125)I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy: a comparison with best supportive care
por: Song, Jingjing, et al.
Publicado: (2017)

Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo
por: Song, Jingjing, et al.
Publicado: (2016)

The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma
por: Zhao, Zhongwei, et al.
Publicado: (2020)

miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
por: Chen, Minjiang, et al.
Publicado: (2018)

A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation
por: Fang, Shiji, et al.
Publicado: (2021)

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
por: Zheng, Liyun, et al.
Publicado: (2021)

TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC
por: Tang, Bufu, et al.
Publicado: (2023)

LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A
por: Fan, Xiaoxi, et al.
Publicado: (2021)

A role for the NPM1/PTPN14/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma
por: Zhang, Dengke, et al.
Publicado: (2022)

Identification of the Potential Metabolic Pathways Involved in the Hepatic Tumorigenesis of Rat Diethylnitrosamine-Induced Hepatocellular Carcinoma via (1)H NMR-Based Metabolomic Analysis
por: Chen, Minjiang, et al.
Publicado: (2019)

ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular Carcinoma
por: Chen, Weiqian, et al.
Publicado: (2020)

Precision interventional radiology
por: Ji, Jiansong, et al.
Publicado: (2021)

Circular RNA Circ0021205 Promotes Cholangiocarcinoma Progression Through MiR-204-5p/RAB22A Axis
por: Tu, Jianfei, et al.
Publicado: (2021)

Diagnosis and prognosis models for hepatocellular carcinoma patient’s management based on tumor mutation burden
por: Tang, Bufu, et al.
Publicado: (2021)

Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress
por: Zhang, Qianqian, et al.
Publicado: (2019)

Corrigendum: Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress
por: Zhang, Qianqian, et al.
Publicado: (2022)

Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3
por: Kong, Chunli, et al.
Publicado: (2023)

Sophoridine suppresses lenvatinib‐resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression
por: Zhao, Zhongwei, et al.
Publicado: (2020)

Drug-eluting beads-transcatheter arterial chemoembolization with or without iodine-125 treatment is effective and tolerable in treating advanced non-small cell lung cancer patients: a pilot study
por: Zhao, Zhongwei, et al.
Publicado: (2020)

Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2
por: Zhu, Jinyu, et al.
Publicado: (2021)

SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells
por: Yang, Yang, et al.
Publicado: (2022)

Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe(3+) as a novel theranostic agent for T1/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer
por: Shu, Gaofeng, et al.
Publicado: (2020)

Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization
por: Chen, Minjiang, et al.
Publicado: (2022)

Multi-algorithms analysis for pre-treatment prediction of response to transarterial chemoembolization in hepatocellular carcinoma on multiphase MRI
por: Chen, Mingzhen, et al.
Publicado: (2023)

Areas of breast tissue covered in cone beam breast CT imaging
por: Xu, Min, et al.
Publicado: (2017)

Delivery strategies of cancer immunotherapy: recent advances and future perspectives
por: Zhao, Zhongwei, et al.
Publicado: (2019)

xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade
por: Tang, Bufu, et al.
Publicado: (2022)

Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE
por: Kong, Chunli, et al.
Publicado: (2021)

Targeted xCT‐mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti‐PD‐1/L1 Response
por: Tang, Bufu, et al.
Publicado: (2022)

USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3
por: Chen, Weiqian, et al.
Publicado: (2021)

Fucoidan-based dual-targeting mesoporous polydopamine for enhanced MRI-guided chemo-photothermal therapy of HCC via P-selectin-mediated drug delivery
por: Shu, Gaofeng, et al.
Publicado: (2022)

Changes in hepatic metabolic profile during the evolution of STZ-induced diabetic rats via an (1)H NMR-based metabonomic investigation
por: Chen, Minjiang, et al.
Publicado: (2019)

Orthotopic hepatocellular carcinoma: molecular imaging-monitored intratumoral hyperthermia-enhanced direct oncolytic virotherapy
por: Song, Jingjing, et al.
Publicado: (2019)

CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway
por: Zhao, Zhongwei, et al.
Publicado: (2020)

Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer
por: Chen, Weiqian, et al.
Publicado: (2016)

Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor Therapy
por: Weng, Qiaoyou, et al.
Publicado: (2021)

Management of patients with intermediate stage hepatocellular carcinoma
por: Prince, David, et al.
Publicado: (2020)

Corrigendum: LncRNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma via Modulating miR-326 and RhoA-ROCK Signaling Pathway
por: Tu, Jianfei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_46n8v79qgpke28em3pavtn22j5